ADAMTS5
| ADAM metallopeptidase with thrombospondin type 1 motif, 5 (aggrecanase-2) | |
|---|---|
| Identifiers | |
| Symbol | ADAMTS5 |
| Entrez | 11096 |
| HUGO | 221 |
| OMIM | 605007 |
| RefSeq | NM_007038 |
| UniProt | Q9UNA0 |
| Other data | |
| Locus | Chr. 21 q22.1-q22 |
|
WikiDoc Resources for ADAMTS5 |
|
Articles |
|---|
|
Most recent articles on ADAMTS5 |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on ADAMTS5 at Clinical Trials.gov Clinical Trials on ADAMTS5 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on ADAMTS5
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating ADAMTS5 Risk calculators and risk factors for ADAMTS5
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for ADAMTS5 |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
ADAMTS5 (aggrecanase) is an enzyme that destroys cartilage in mice. Its discovery may lead to progress in human arthritis research. This enzyme may also be involved in cartilage deterioration in humans. It has been isolated and identified by Australian scientists in Sydney. ADAMTS5 has been indicated as being important in early osteoarthritis.
External links